Clinical trial
Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non-hematological Cancer Treated With Intravenous Anti-tumor Therapy
NCT02279121 is registered in ClinicalTrials.gov with Centre Hospitalier Régional Metz-Thionville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non-hematological Cancer Treated With Intravenous Anti-tumor Therapy
- Lead sponsor
- Centre Hospitalier Régional Metz-Thionville
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- March 31, 2016
- Enrollment
- 162 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.